We use some essential cookies to make this website work.
We鈥檇 like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Modelled proportion of the population (prevalence) in England and Scotland currently infected with SARS-CoV-2 (COVID-19), incidence of new infections, the infection hospitalisation rate (IHR) and the infection fatality risk 鈥�
Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.
Uptake of the seasonal influenza vaccine in frontline healthcare workers during the 2023 to 2024 influenza vaccination programme in England.
Report on the uptake of influenza vaccine in GP patients during the 2023 to 2024 influenza vaccination programme in England.
Analysis of data on non-travel associated shigella infections in England.
Evaluation of the ninth year of the shingles vaccination programme in England: financial year 2022 to 2023.
This rapid mapping review identifies and categorises evidence on the health equity impacts of climate change in the UK.
This rapid review summarises available evidence on infectious disease transmission risk in communal accommodation settings.
Quarterly reports, with commentary, on cases confirmed by UK Health Security Agency's Virus Reference Department or local laboratory testing.
This report (XXVI) is a review of suspected overexposures investigated by chromosomal aberration analysis.
Report presenting data for sexually transmitted infections (STIs) in the East of England.
Cumulative data showing the number of GP-registered patients in England having the seasonal influenza vaccine.
Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Prevenar 13 vaccine.
Cumulative data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevenar 13 in England.
Qualitative assessment of the risk that Crimean-Congo haemorrhagic fever presents to the UK population.
Data showing the number and proportion of frontline healthcare workers (HCWs) in England having seasonal influenza and COVID-19 vaccines.
皇冠体育appse reports summarise the performance of different lateral flow devices (LFDs) used across various test settings and services within the National Testing Programme.
This report outlines the findings of 2 large-scale asymptomatic testing interventions in education settings.
This report presents the comparison of the sensitivity data provided by the manufacturer in the instructions for use with that observed in the laboratories at Porton Down.
This paper presents empirical estimates of the impact of the TTSP scheme on testing uptake amongst those who received the payments.
Don鈥檛 include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we鈥檇 like to know more about your visit today. .